North Chemical Industries Past Earnings Performance
Past criteria checks 0/6
North Chemical Industries's earnings have been declining at an average annual rate of -23.1%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been declining at an average rate of 3.5% per year.
Key information
-23.1%
Earnings growth rate
-23.5%
EPS growth rate
Chemicals Industry Growth | 12.1% |
Revenue growth rate | -3.5% |
Return on equity | -0.2% |
Net Margin | -0.1% |
Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Optimistic Investors Push North Chemical Industries Co., Ltd. (SZSE:002246) Shares Up 34% But Growth Is Lacking
Oct 16There's Reason For Concern Over North Chemical Industries Co., Ltd.'s (SZSE:002246) Massive 27% Price Jump
Aug 28North Chemical Industries (SZSE:002246) Has Announced A Dividend Of CN¥0.05
Jul 05What North Chemical Industries Co., Ltd.'s (SZSE:002246) 34% Share Price Gain Is Not Telling You
May 21Some Investors May Be Willing To Look Past North Chemical Industries' (SZSE:002246) Soft Earnings
May 06Revenue & Expenses Breakdown
How North Chemical Industries makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 24 | 1,979 | -3 | 363 | 97 |
30 Jun 24 | 2,101 | 47 | 375 | 92 |
31 Mar 24 | 2,066 | 36 | 380 | 86 |
31 Dec 23 | 2,159 | 56 | 363 | 83 |
30 Sep 23 | 2,170 | 18 | 316 | 88 |
30 Jun 23 | 2,226 | 73 | 293 | 93 |
31 Mar 23 | 2,408 | 86 | 293 | 115 |
01 Jan 23 | 2,559 | 93 | 306 | 117 |
30 Sep 22 | 2,527 | 134 | 271 | 115 |
30 Jun 22 | 2,618 | 132 | 271 | 120 |
31 Mar 22 | 2,645 | 110 | 286 | 112 |
01 Jan 22 | 2,633 | 122 | 289 | 110 |
30 Sep 21 | 2,657 | 96 | 293 | 108 |
30 Jun 21 | 2,689 | 111 | 289 | 94 |
31 Mar 21 | 2,530 | 115 | 266 | 94 |
31 Dec 20 | 2,359 | 90 | 289 | 94 |
30 Sep 20 | 2,387 | 98 | 287 | 112 |
30 Jun 20 | 2,335 | 95 | 319 | 114 |
31 Mar 20 | 2,402 | 133 | 337 | 102 |
31 Dec 19 | 2,461 | 137 | 322 | 96 |
30 Sep 19 | 2,584 | 157 | 379 | 82 |
30 Jun 19 | 2,475 | 136 | 338 | 90 |
31 Mar 19 | 2,459 | 133 | 328 | 84 |
31 Dec 18 | 2,363 | 124 | 308 | 85 |
30 Sep 18 | 2,291 | 117 | 302 | 85 |
30 Jun 18 | 2,311 | 118 | 289 | 101 |
31 Mar 18 | 2,125 | 92 | 291 | 84 |
31 Dec 17 | 2,183 | 108 | 307 | 72 |
30 Sep 17 | 2,237 | 105 | 371 | 45 |
30 Jun 17 | 2,118 | 121 | 403 | 0 |
31 Mar 17 | 2,321 | 143 | 440 | 0 |
31 Dec 16 | 2,193 | 138 | 416 | 0 |
30 Sep 16 | 1,711 | 115 | 317 | 0 |
30 Jun 16 | 1,606 | 101 | 283 | 0 |
31 Mar 16 | 1,386 | 58 | 209 | 0 |
31 Dec 15 | 1,505 | 55 | 204 | 0 |
30 Sep 15 | 1,713 | 64 | 196 | 0 |
30 Jun 15 | 1,944 | 65 | 203 | 0 |
31 Mar 15 | 1,999 | 66 | 215 | 0 |
31 Dec 14 | 2,036 | 73 | 219 | 0 |
30 Sep 14 | 2,095 | 71 | 228 | 0 |
30 Jun 14 | 2,050 | 60 | 228 | 0 |
31 Mar 14 | 2,048 | 53 | 221 | 0 |
31 Dec 13 | 2,013 | 49 | 219 | 0 |
Quality Earnings: 002246 is currently unprofitable.
Growing Profit Margin: 002246 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 002246 is unprofitable, and losses have increased over the past 5 years at a rate of 23.1% per year.
Accelerating Growth: Unable to compare 002246's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 002246 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-5.3%).
Return on Equity
High ROE: 002246 has a negative Return on Equity (-0.19%), as it is currently unprofitable.